Polycystic ovary syndrome (PCOS) is a leading cause of infertility in women. Five to 10% of premenopausal women are estimated to be affected by this disease, which is characterized by hyperandrogenemia, chronic anovulation, and is associated with other health risks such as type 2 diabetes mellitus and obesity. A primary defect in PCOS resides in the ovary, with increased (thecal/stromal) androgen production and follicular maturation arrest being the hallmarks. Unique changes in PCOS ovarian morphology, hyperplasia and thickening of the cortical ovarian stroma and hypertrophy of the stroma at the cortical-medullary boundary, suggest the possible involvement of the ovarian stroma. Previous investigators have postulated that the increased stromal density could be a cause of PCOS or a result of a primary ovarian deficit. We hypothesize that there is a bi-directional dialogue between the stroma and theca that influences the activities of these two compartments. The long-term objective of this project is to elucidate the role ovarian stromal cells play in the etiology of PCOS. This objective will be attained by completing the following specific aims: 1) define ovarian stromal cell paracrine interactions with thecal cells focusing on steroidogenesis and growth factor/growth factor binding protein production; and 2) determine whether PCOS ovarian stromal cells have functional defect(s) that result in the manifestation of the thecal PCOS phenotype, or whether stromal cells exhibit an altered phenotype because of interaction with PCOS thecal cells. To examine stromal cell function and paracrine theca interactions, cell culture experiments will be performed. The effects of androgens, progesterone, gonadotropins and cAMP treatment on stromal cell proliferation, steroidogenic potential and growth factor/growth factor binding protein production will be evaluated using radioimmunoassays, ELISAs, Western blots, and quantitative real-time RT-PCR. Paracrine interactions between stromal and thecal cells will be evaluated by testing conditioned medium from each cell type on the other cell type and by co-culture of thecal and stromal cells. Identification of the paracrine factor(s) expressed by ovarian stromal cells that influence theca cells will be initiated using standard fractionation procedures, followed by state-of-the-art proteomic and lipid/small molecule approaches. Lastly, we will examine PCOS stromal and thecal cell interactions, determining if they differ from normal ovarian stromal/thecal interactions. These studies should elucidate for the first time the functional role of ovarian stromal cells, and their role in PCOS. ? ?

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
3U54HD034449-07S1
Application #
6610866
Study Section
Special Emphasis Panel (ZHD1-DRG-D (SJ))
Program Officer
Leppert, Phyllis C
Project Start
1996-12-01
Project End
2007-03-31
Budget Start
2003-04-28
Budget End
2004-03-31
Support Year
7
Fiscal Year
2003
Total Cost
$129,827
Indirect Cost
Name
University of Pennsylvania
Department
Obstetrics & Gynecology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Gorsic, Lidija K; Kosova, Gulum; Werstein, Brian et al. (2017) Pathogenic Anti-Müllerian Hormone Variants in Polycystic Ovary Syndrome. J Clin Endocrinol Metab 102:2862-2872
Legro, Richard S; Kunselman, Allen R; Stetter, Christy M et al. (2017) Normal Pubertal Development in Daughters of Women With PCOS: A Controlled Study. J Clin Endocrinol Metab 102:122-131
Ketefian, Aline; Jones, Michelle R; Krauss, Ronald M et al. (2016) Association study of androgen signaling pathway genes in polycystic ovary syndrome. Fertil Steril 105:467-73.e4
Tee, Meng Kian; Speek, Mart; Legeza, Balázs et al. (2016) Alternative splicing of DENND1A, a PCOS candidate gene, generates variant 2. Mol Cell Endocrinol 434:25-35
Dumesic, Daniel A; Oberfield, Sharon E; Stener-Victorin, Elisabet et al. (2015) Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome. Endocr Rev 36:487-525
Hayes, M Geoffrey; Urbanek, Margrit; Ehrmann, David A et al. (2015) Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations. Nat Commun 6:7502
Brower, Meredith A; Jones, Michelle R; Rotter, Jerome I et al. (2015) Further investigation in europeans of susceptibility variants for polycystic ovary syndrome discovered in genome-wide association studies of Chinese individuals. J Clin Endocrinol Metab 100:E182-6
Du, Ping; Camacho, Fabian; McCall-Hosenfeld, Jennifer et al. (2015) Human Papillomavirus Vaccination Among Adults and Children in 5 US States. J Public Health Manag Pract 21:573-83
Feiner, John R; Gropper, Michael A; Toy, Pearl et al. (2015) A Clinical Trial to Detect Subclinical Transfusion-induced Lung Injury during Surgery. Anesthesiology 123:126-35
McAllister, Jan M; Legro, Richard S; Modi, Bhavi P et al. (2015) Functional genomics of PCOS: from GWAS to molecular mechanisms. Trends Endocrinol Metab 26:118-24

Showing the most recent 10 out of 153 publications